Oneness Biotech Statistics
Total Valuation
Oneness Biotech has a market cap or net worth of TWD 33.46 billion. The enterprise value is 27.35 billion.
Market Cap | 33.46B |
Enterprise Value | 27.35B |
Important Dates
The last earnings date was Friday, March 7, 2025.
Earnings Date | Mar 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Oneness Biotech has 478.03 million shares outstanding. The number of shares has increased by 0.97% in one year.
Current Share Class | n/a |
Shares Outstanding | 478.03M |
Shares Change (YoY) | +0.97% |
Shares Change (QoQ) | +0.07% |
Owned by Insiders (%) | 7.64% |
Owned by Institutions (%) | 6.07% |
Float | 308.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 283.85 |
PB Ratio | 2.72 |
P/TBV Ratio | 3.01 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -23.47 |
EV / Sales | 231.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -69.19 |
Financial Position
The company has a current ratio of 39.87, with a Debt / Equity ratio of 0.03.
Current Ratio | 39.87 |
Quick Ratio | 38.90 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | -1.03 |
Interest Coverage | -113.02 |
Financial Efficiency
Return on equity (ROE) is -8.45% and return on invested capital (ROIC) is -4.83%.
Return on Equity (ROE) | -8.45% |
Return on Assets (ROA) | -4.68% |
Return on Invested Capital (ROIC) | -4.83% |
Return on Capital Employed (ROCE) | -8.06% |
Revenue Per Employee | 2.74M |
Profits Per Employee | -27.10M |
Employee Count | 43 |
Asset Turnover | 0.01 |
Inventory Turnover | 0.46 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.39% in the last 52 weeks. The beta is 1.71, so Oneness Biotech's price volatility has been higher than the market average.
Beta (5Y) | 1.71 |
52-Week Price Change | -57.39% |
50-Day Moving Average | 76.82 |
200-Day Moving Average | 118.41 |
Relative Strength Index (RSI) | 40.89 |
Average Volume (20 Days) | 2,693,331 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oneness Biotech had revenue of TWD 117.93 million and -1.17 billion in losses. Loss per share was -2.44.
Revenue | 117.93M |
Gross Profit | 63.03M |
Operating Income | -1.09B |
Pretax Income | -1.15B |
Net Income | -1.17B |
EBITDA | -681.01M |
EBIT | -1.09B |
Loss Per Share | -2.44 |
Balance Sheet
The company has 7.02 billion in cash and 406.35 million in debt, giving a net cash position of 6.61 billion or 13.83 per share.
Cash & Cash Equivalents | 7.02B |
Total Debt | 406.35M |
Net Cash | 6.61B |
Net Cash Per Share | 13.83 |
Equity (Book Value) | 12.80B |
Book Value Per Share | 25.73 |
Working Capital | 7.11B |
Cash Flow
In the last 12 months, operating cash flow was -345.58 million and capital expenditures -49.71 million, giving a free cash flow of -395.28 million.
Operating Cash Flow | -345.58M |
Capital Expenditures | -49.71M |
Free Cash Flow | -395.28M |
FCF Per Share | -0.83 |
Margins
Gross Margin | 53.45% |
Operating Margin | -920.96% |
Pretax Margin | -974.96% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Oneness Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.97% |
Shareholder Yield | -0.97% |
Earnings Yield | -3.48% |
FCF Yield | -1.18% |
Stock Splits
The last stock split was on July 26, 2024. It was a forward split with a ratio of 1.049967976.
Last Split Date | Jul 26, 2024 |
Split Type | Forward |
Split Ratio | 1.049967976 |
Scores
Oneness Biotech has an Altman Z-Score of 48.44.
Altman Z-Score | 48.44 |
Piotroski F-Score | n/a |